Update -- cellectar biosciences to announce second quarter financial results and host a conference call on tuesday, august 13, 2024

Florham park, n.j., aug. 08, 2024 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will provide a corporate update for the three months ended june 30, 2024, on tuesday, august 13, 2024. management will also host a conference call with investors to discuss financial results and provide an overview at 8:30 am eastern time. details for the call are as follows:
CLRB Ratings Summary
CLRB Quant Ranking